Your browser doesn't support javascript.
loading
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome.
Iurlo, Alessandra; Nobili, Alessandro; Latagliata, Roberto; Bucelli, Cristina; Castagnetti, Fausto; Breccia, Massimo; Abruzzese, Elisabetta; Cattaneo, Daniele; Fava, Carmen; Ferrero, Dario; Gozzini, Antonella; Bonifacio, Massimiliano; Tiribelli, Mario; Pregno, Patrizia; Stagno, Fabio; Vigneri, Paolo; Annunziata, Mario; Cavazzini, Francesco; Binotto, Gianni; Mansueto, Giovanna; Russo, Sabina; Falzetti, Franca; Montefusco, Enrico; Gugliotta, Gabriele; Storti, Sergio; D'Addosio, Ada M; Scaffidi, Luigi; Cortesi, Laura; Cedrone, Michele; Rossi, Antonella Russo; Avanzini, Paolo; Mauro, Endri; Spadea, Antonio; Celesti, Francesca; Giglio, Gianfranco; Isidori, Alessandro; Crugnola, Monica; Calistri, Elisabetta; Sorà, Federica; Rege-Cambrin, Giovanna; Sica, Simona; Luciano, Luigiana; Galimberti, Sara; Orlandi, Ester M; Bocchia, Monica; Tettamanti, Mauro; Alimena, Giuliana; Saglio, Giuseppe; Rosti, Gianantonio; Mannucci, Pier Mannuccio.
Afiliação
  • Iurlo A; Oncohematology Division, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy.
  • Nobili A; Department of Neuroscience, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
  • Latagliata R; Department of Cellular Biotechnologies and Hematology, University "La Sapienza" of Rome, Rome, Italy.
  • Bucelli C; Oncohematology Division, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy.
  • Castagnetti F; Institute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, "S. Orsola-Malpighi" University Hospital, University of Bologna, Bologna, Italy.
  • Breccia M; Department of Cellular Biotechnologies and Hematology, University "La Sapienza" of Rome, Rome, Italy.
  • Abruzzese E; Hematology Unit, Sant'Eugenio Hospital, Rome, Italy.
  • Cattaneo D; Oncohematology Division, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy.
  • Fava C; Division of Hematology and Internal Medicine, University of Turin, "San Luigi Gonzaga" University Hospital, Orbassano, Turin, Italy.
  • Ferrero D; Hematology Unit, University of Turin, Turin, Italy.
  • Gozzini A; Haematology, AOU Careggi, University of Firenze, Firenze, Italy.
  • Bonifacio M; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Tiribelli M; Division of Hematology and BMT, Azienda Ospedaliero - Universitaria di Udine, Udine, Italy.
  • Pregno P; Hematology Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy.
  • Stagno F; Hematology Unit, Ferrarotto Hospital, Catania, Italy.
  • Vigneri P; Hematology Unit, Ferrarotto Hospital, Catania, Italy.
  • Annunziata M; Hematology Unit, Cardarelli Hospital, Naples, Italy.
  • Cavazzini F; Hematology Unit, University of Ferrara, Ferrara, Italy.
  • Binotto G; Hematology Unit, University of Padova, Padova, Italy.
  • Mansueto G; Department of Onco-Hematology, IRCCS-CROB, Rionero in Vulture, Italy.
  • Russo S; Hematology Unit, AOU G. Martino, Messina, Italy.
  • Falzetti F; Division of Hematology and Clinical Immunology, Department of Medicine, University of Perugia, Perugia, Italy.
  • Montefusco E; Hematology Unit, Sant'Andrea Hospital, Rome, Italy.
  • Gugliotta G; Institute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, "S. Orsola-Malpighi" University Hospital, University of Bologna, Bologna, Italy.
  • Storti S; Onco-Hematology Unit, Università Cattolica Giovanni Paolo II, Campobasso, Italy.
  • D'Addosio AM; Immunohematology and Trasfusional Medicine Division, S. Pietro Fatebenefratelli Hospital, Rome, Italy.
  • Scaffidi L; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Cortesi L; Department of Neuroscience, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
  • Cedrone M; Hematology Unit, S. Giovanni Hospital, Rome, Italy.
  • Rossi AR; Hematology and Transplants Unit, University of Bari, Bari, Italy.
  • Avanzini P; Hematology, Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia, Italy.
  • Mauro E; Department of Internal Medicine, Pordenone General Hospital, Pordenone, Italy.
  • Spadea A; Hematology and Stem Cell Transplantation Unit, Regina Elena Institute, Rome, Italy.
  • Celesti F; Hematology Unit, Belcolle Hospital, Viterbo, Italy.
  • Giglio G; Hematology Unit, Campobasso Hospital, Campobasso, Italy.
  • Isidori A; Hematology Unit, Pesaro Hospital, Pesaro, Italy.
  • Crugnola M; Hematology and BMT Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Calistri E; Hematology Unit, Treviso Hospital, Treviso, Italy.
  • Sorà F; Institute of Hematology, Università Cattolica Sacro Cuore, Rome, Italy.
  • Rege-Cambrin G; Division of Hematology and Internal Medicine, University of Turin, "San Luigi Gonzaga" University Hospital, Orbassano, Turin, Italy.
  • Sica S; Institute of Hematology, Università Cattolica Sacro Cuore, Rome, Italy.
  • Luciano L; Hematology Unit, ''Federico II'' Hospital, University of Naples, Naples, Italy.
  • Galimberti S; Department of Clinical and Experimental Medicine, Section of Hematology - University of Pisa, Pisa, Italy.
  • Orlandi EM; Oncology-Hematology Department, Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Bocchia M; Hematology Unit, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy.
  • Tettamanti M; Department of Neuroscience, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
  • Alimena G; Department of Cellular Biotechnologies and Hematology, University "La Sapienza" of Rome, Rome, Italy.
  • Saglio G; Division of Hematology and Internal Medicine, University of Turin, "San Luigi Gonzaga" University Hospital, Orbassano, Turin, Italy.
  • Rosti G; Institute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, "S. Orsola-Malpighi" University Hospital, University of Bologna, Bologna, Italy.
  • Mannucci PM; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation and University of Milan, Milan, Italy.
Oncotarget ; 7(48): 80083-80090, 2016 Nov 29.
Article em En | MEDLINE | ID: mdl-27579540
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Polimedicação / Mesilato de Imatinib / Antineoplásicos Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Polimedicação / Mesilato de Imatinib / Antineoplásicos Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article